Indeterminate pulmonary nodules in patients with sarcoma affect survival

Stacy Rissing, Bruce T. Rougraff, Kenneth Davis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We prospectively studied 331 sarcoma patients treated between April 1999 and December 2004 to see if small, indeterminate pulmonary nodules are of prognostic significance. Seventy-one (21%) had indeterminate pulmonary nodules on initial spiral CCT. Twenty of 71 (28%) patients with indeterminate nodules progressed with metastatic disease. Metastatic disease developed in 18/20 (90%) in the area of the original indeterminate nodule. The presence of tiny (<5 mm) indeterminate nodules was not a prognostic variable, however, the presence of nodules ≥5 mm was associated with worse 3 year disease-free survival compared to those with no nodules or tiny nodules (81% versus 49%) but better than those with definite metastatic disease at presentation (49% versus 5%). Because patients with pulmonary nodules ≥5 mm are at increased risk for metastatic disease compared to patients with normal CCT or those with <5 mm nodules but better survival than patients with Stage IV disease, we believe a new staging system of these patients should be considered and recommend careful followup.

Original languageEnglish
Pages (from-to)118-121
Number of pages4
JournalClinical Orthopaedics and Related Research
Issue number459
DOIs
StatePublished - Jun 2007

Fingerprint

Sarcoma
Lung
Survival
Disease-Free Survival

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Indeterminate pulmonary nodules in patients with sarcoma affect survival. / Rissing, Stacy; Rougraff, Bruce T.; Davis, Kenneth.

In: Clinical Orthopaedics and Related Research, No. 459, 06.2007, p. 118-121.

Research output: Contribution to journalArticle

@article{228c62ed1fc5426a8ecc61190fb8d41d,
title = "Indeterminate pulmonary nodules in patients with sarcoma affect survival",
abstract = "We prospectively studied 331 sarcoma patients treated between April 1999 and December 2004 to see if small, indeterminate pulmonary nodules are of prognostic significance. Seventy-one (21{\%}) had indeterminate pulmonary nodules on initial spiral CCT. Twenty of 71 (28{\%}) patients with indeterminate nodules progressed with metastatic disease. Metastatic disease developed in 18/20 (90{\%}) in the area of the original indeterminate nodule. The presence of tiny (<5 mm) indeterminate nodules was not a prognostic variable, however, the presence of nodules ≥5 mm was associated with worse 3 year disease-free survival compared to those with no nodules or tiny nodules (81{\%} versus 49{\%}) but better than those with definite metastatic disease at presentation (49{\%} versus 5{\%}). Because patients with pulmonary nodules ≥5 mm are at increased risk for metastatic disease compared to patients with normal CCT or those with <5 mm nodules but better survival than patients with Stage IV disease, we believe a new staging system of these patients should be considered and recommend careful followup.",
author = "Stacy Rissing and Rougraff, {Bruce T.} and Kenneth Davis",
year = "2007",
month = "6",
doi = "10.1097/BLO.0b013e31805d8606",
language = "English",
pages = "118--121",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "459",

}

TY - JOUR

T1 - Indeterminate pulmonary nodules in patients with sarcoma affect survival

AU - Rissing, Stacy

AU - Rougraff, Bruce T.

AU - Davis, Kenneth

PY - 2007/6

Y1 - 2007/6

N2 - We prospectively studied 331 sarcoma patients treated between April 1999 and December 2004 to see if small, indeterminate pulmonary nodules are of prognostic significance. Seventy-one (21%) had indeterminate pulmonary nodules on initial spiral CCT. Twenty of 71 (28%) patients with indeterminate nodules progressed with metastatic disease. Metastatic disease developed in 18/20 (90%) in the area of the original indeterminate nodule. The presence of tiny (<5 mm) indeterminate nodules was not a prognostic variable, however, the presence of nodules ≥5 mm was associated with worse 3 year disease-free survival compared to those with no nodules or tiny nodules (81% versus 49%) but better than those with definite metastatic disease at presentation (49% versus 5%). Because patients with pulmonary nodules ≥5 mm are at increased risk for metastatic disease compared to patients with normal CCT or those with <5 mm nodules but better survival than patients with Stage IV disease, we believe a new staging system of these patients should be considered and recommend careful followup.

AB - We prospectively studied 331 sarcoma patients treated between April 1999 and December 2004 to see if small, indeterminate pulmonary nodules are of prognostic significance. Seventy-one (21%) had indeterminate pulmonary nodules on initial spiral CCT. Twenty of 71 (28%) patients with indeterminate nodules progressed with metastatic disease. Metastatic disease developed in 18/20 (90%) in the area of the original indeterminate nodule. The presence of tiny (<5 mm) indeterminate nodules was not a prognostic variable, however, the presence of nodules ≥5 mm was associated with worse 3 year disease-free survival compared to those with no nodules or tiny nodules (81% versus 49%) but better than those with definite metastatic disease at presentation (49% versus 5%). Because patients with pulmonary nodules ≥5 mm are at increased risk for metastatic disease compared to patients with normal CCT or those with <5 mm nodules but better survival than patients with Stage IV disease, we believe a new staging system of these patients should be considered and recommend careful followup.

UR - http://www.scopus.com/inward/record.url?scp=34249952288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249952288&partnerID=8YFLogxK

U2 - 10.1097/BLO.0b013e31805d8606

DO - 10.1097/BLO.0b013e31805d8606

M3 - Article

C2 - 17438474

AN - SCOPUS:34249952288

SP - 118

EP - 121

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 459

ER -